Utah Medical Products UTMD England And Australia — Construction In Progress Gross

Similar metrics at other companies

WELLConstruction in progress

$764.22M-26.9%

EPRConstruction in progress

$23.38M-80.2%

BRCEurope & Australia — Segment, Expenditure, Addition to Long-Lived Assets

$1.14M-33.4%

JBGSConstruction in progress

$186.58M-43.0%

EQRConstruction in progress

$85.97M-40.6%

MMSIConstruction in progress

$90.99M+42.8%

Other financials

Income statement

See full

Revenue$8.7M-10.2%

Gross profit$5.3M-4.6%

Operating income$2.6M-18.6%

Net income$2.6M-14.4%

EPS (diluted)$0.82-10.9%

Balance sheet

See full

Cash & equivalents$87.4M+4.9%

Total debt$210.0K—

Total equity$120.4M+2.8%

Total assets$124.4M+1.5%

Cash flow

See full

Operating cash flow$3.1M-30.4%

CapEx$130.0K-29.3%

Free cash flow$3.0M-30.4%

Valuation

See full

Market cap$219.63M+26.4%

Enterprise value$132.44M+42.5%

P/E20.3×+6.4×

P/S5.9×+1.4×

Profitability

See full

Gross margin57.9%-0.4pp

Operating margin28.8%-3.9pp

Net margin28.9%-4.1pp

FCF margin34.7%0.0pp

Returns & leverage

See full

Return on equity9.1%-1.4pp

Debt / equity0×—

Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:ConstructionInProgressGross.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's england and australia — construction in progress gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Utah Medical Products's england and australia — construction in progress gross?: Utah Medical Products (UTMD) reported england and australia — construction in progress gross of $0 in Q4 2025.
What does england and australia — construction in progress gross mean?: The accumulated costs for capital projects currently under development within the England and Australia geographic segment that are not yet placed into service. It serves as a leading indicator of future capacity expansion or facility upgrades in these markets.